Publications database

This publication is a user-friendly guide, taking the reader, step by step, through the trendspotter methodology developed by the EMCDDA to explore emerging drug trends, new patterns of use, developing drug markets...

One page flyer promoting the publication Medical use of cannabis and cannabinoids: questions and answers for policymaking, published in December 2018.

This page describes the work and main outputs of the EU Early Warning System on new psychoactive substances. It includes a description of how the system work, an historical timeline of legislation...

This document is an update of the International Cooperation Strategy adopted in 2007. It sets priorities in the area of the international cooperation aligned with the Centre’s Strategy 2025.

The EMCDDA receives stable funding under Commission budget line B3-441 of the general budget of the European Union. Each year, a preliminary draft budget is presented by the Centre's Director to the...

Partnership is a guiding principle for the EMCDDA as it works to increase its understanding of the external dimension of the drug phenomenon and its implications for public health and security in...

These are the EMCDDA's final annual accounts for the financial year 2017.

The General Report of Activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its...

This brochure provides an overview of the 2018 European Drug Report package and includes a brief summary of the main headlines.

For more than 20 years, the European information network on drugs and drug addiction (Reitox), has been the cornerstone of the European drug monitoring and reporting system, to which it contributes by...